Trial intelligence / Profile preview

Vaginal estrogen cream to reduce complications in women using a vaginal pessary for genital prolapse

RBR-23sqxzCompleted

Sponsor
Universidade Estadual de Campinas
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of DehydraTECH-estrogen in pelvic organ prolapse (POP), uterine prolapse and cystocele (2 arms), sponsored by Universidade Estadual de Campinas. Started Aug 2018; status: completed.

02

Drugs

DehydraTECH-estrogen
03

Conditions

pelvic organ prolapse (POP)uterine prolapsecystocele

Beyond the preview

Go deeper on RBR-23sqxz.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-23sqxz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call